Header image

6E. HIV&AIDS Session: Discovery & translational science: HIV Cure Session 2 – Advances, Attitudes and Aspirations for HIV Elimination

Tracks
Tuesday, September 15, 2026
11:00 AM - 12:30 PM
Albert

Speaker

Agenda Item Image
Dr. Bruce Walker
Institute Director
Ragon Institute of MGB, MIT and Harvard

The global quest for durable immune control of HIV

11:00 AM - 11:45 AM

Biography

Dr. Walker is a physician-scientist, the founding and current Institute Director of the Ragon Institute of Mass General Brigham, MIT and Harvard, and a Howard Hughes Medical Institute investigator. His laboratory studies T cell immune responses to chronic viral infections, using HIV as a model system.
HIV&AIDS Conference

Panel Discussion - Towards HIV Cure: Perspectives from Community, Clinic and Research

11:45 AM - 12:30 PM

Biography

Agenda Item Image
Dr Jillian Lau
Infectious Diseases Physician
Doherty Institute

Panel Discussion - HIV Cure

11:45 AM - 12:30 PM

Biography

Dr Jillian Lau is an Infectious Diseases physician based in Melbourne, Victoria. She works clinically at Alfred Health and Monash Health and is a postdoctoral research fellow at The Doherty Institute. Her research focuses on HIV cure therapeutic interventions, and the practice of interrupting antiretroviral therapy in HIV cure trials (known as analytical treatment interruptions).
Agenda Item Image
Mr Michael McKillop
Patient
Alfred Id Clinic

Panel Member

11:45 AM - 12:30 PM

Biography

Agenda Item Image
Dr. Rachel Rutishauser
Associate Professor
University Of California, San Francisco

Panel Member

11:45 AM - 12:30 PM

Biography

Rachel Rutishauser, MD, PhD is an Infectious Disease physician-scientist and Associate Professor in the Division of Experimental Medicine at the University of California, San Francisco. The Rutishauser laboratory studies immunologic mechanisms of HIV control.
Agenda Item Image
A/Prof Anna Hearps
Research Scientist
Burnet Institute

Panel Member

11:45 AM - 12:30 PM

Biography

Dr Hearps is Co-Director of the Disease Elimination Program and Head of the Infection, Inflammation and Innate Immunity laboratory the Burnet Institute. Her research focuses on the pathogenesis and clinical manifestations of HIV, with a particular focus on innate immune cells, and implications for chronic diseases including cardiovascular disease.
Agenda Item Image
Mr Mauricio Gomez Mejia
Peer Services Coordinator
Queensland Positive People

Panel Member

11:45 AM - 12:30 PM

Biography

Mao Gomez is the Peer Services Coordinator at Queensland Positive People, leading Peer Navigation, community engagement, and peer-led programs for people living with HIV across Queensland. With a background in HIV testing, peer support, and AOD prevention, Mao works to strengthen peer-led service delivery through trauma-informed, community-centred approaches. His work focuses on improving health outcomes, building meaningful community connections, and ensuring lived experience remains central to program development, service design, and systems advocacy within the HIV sector.
Agenda Item Image
Dr Jared Stern
Post-Doctoral Research Fellow
The Peter Doherty Institute for Infection and Immunity

Panel Member

11:45 AM - 12:30 PM

Biography

Jared Stern has a background in HIV reservoir biology and proviral sequencing techniques, having found that circadian rhythms and acute stress affect HIV transcriptional activity. They have been living with HIV for over 10 years and are passionate about scientific communication and community engagement.

Session Chair

Agenda Item Image
Melissa Churchill
Laboratory Head, Neuroinfections Laboratory
RMIT University, Melbourne

Agenda Item Image
Jillian Lau
Infectious Diseases Physician
Doherty Institute

loading